Beaulieu T, Wood E, Tobias S, Lysyshyn M, Patel P, Matthews J, Ti L Is expected substance type associated with timing of drug checking service utilization?: a cross-sectional study Harm Reduct J PubMed

Beaulieu T, Knight R, Nolan S, Quick O, Ti L Artificial intelligence interventions focused on opioid use disorders: a review of the gray literature Am J Drug Alcohol Abuse PubMed

Beaulieu T, Barbic S, Milloy MJ, Puri N, Hayashi K, Ti L PMH24 Factors associated with receiving integrated care among people with concurrent opioid use disorder and mental illness in a Canadian setting Value Health Link

Beaulieu T, Hayashi K, Dong H, DeBeck K, Day A, McKendry R, Kaur G, Barrios R, Milloy MJ, Ti L Impact of migration from an illicit drug scene on hospital outcomes among people who use illicit drugs in Vancouver, Canada Drug Alcohol Rev PubMed

Beaulieu T, Hayashi K, Nosova E, Milloy MJ, DeBeck K, Wood E, Kerr T, Ti L Effect of witnessing an overdose on the use of drug checking services among people who use illicit drugs in Vancouver, Canada Am J Drug Alcohol Abuse PubMed

Beaulieu T, Nolan S, Ti L Hepatitis C treatment among incarcerated individuals in Canada and strategies to prevent reinfection in the postrelease period J Epidemiol Community Health PubMed

Kim B, Nolan S, Beaulieu T, Shalansky S, Ti L Inappropriate opioid prescribing practices: a narrative review Am J Health Syst Pharm PubMed

Beaulieu T, Hayashi K, Milloy MJ, Nosova E, DeBeck K, Montaner J, Kerr T, Ti L HIV serostatus and having access to a physician for regular hepatitis C virus care among people who inject drugs J Acquir Immune Defic Syndr PubMed

Beaulieu T, Ti L, Milloy MJ, Nosova E, Wood E, Hayashi K Major depressive disorder and access to health services among people who use illicit drugs in Vancouver, Canada Subst Abuse Treat Prev Policy PubMed